Mirae Asset Global Etfs Holdings Ltd. Revolution Medicines, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 109,004 shares of RVMD stock, worth $4.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
109,004
Previous 102,127
6.73%
Holding current value
$4.42 Million
Previous $4.47 Million
13.72%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$674 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$549 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$544 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$478 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$414 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.56B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...